Generic pharmaceutical company Accord Healthcare Inc, part of India-based Intas Pharmaceuticals, announced on Tuesday that it has launched Clomiphene tablets, the generic equivalent of CLOMID (clomiphene citrate), in the United States.

The new product is intended for the treatment of ovulatory dysfunction in women desiring pregnancy.

Chrys Kokino, president of Accord Healthcare North America, said: "Our primary focus will always be to provide access to high quality, essential medicines for all patients and ensure a positive patient experience. We are pleased to be able to provide Accord Clomiphene tablets as another option for those women who may need this medication. We look forward to continuing to launch and support important products specifically focused on women's healthcare."